Reaction
Nsaid Exacerbated Respiratory Disease reporting signals
As of the last recalculation, Nsaid Exacerbated Respiratory Disease appears in 350 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is UMECLIDINIUM (PRR 111.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Umeclidinium | 16 | 111.3 | 111.5 |
| Fluticasone Furoate | 21 | 109.6 | 109.8 |
| Ibuprofen Capsule | 172 | 99.9 | 99.9 |
| Ibuprofen Tablet, Film Coated | 172 | 99.9 | 99.9 |
| Ibupfrofen | 172 | 99.9 | 99.9 |
| Ibuprofen Tablets Usp, 200Mg | 172 | 99.9 | 99.9 |
| Ibuprofen Oral | 172 | 99.8 | 99.9 |
| Ibuprofen Capsules 200 Mg | 172 | 99.8 | 99.9 |
| Ibuprofen 200 Mg | 172 | 99.8 | 99.9 |
| Ibuprofen 200Mg | 172 | 99.8 | 99.9 |
| Ketoprofen | 15 | 71.0 | 71.1 |
| Mepolizumab | 30 | 39.2 | 39.2 |